Dusseldorf - Delayed Quote EUR
Ultragenyx Pharmaceutical Inc (UP0.DU)
32.60
+2.00
+(6.54%)
At close: April 23 at 7:30:39 PM GMT+2
Loading Chart for UP0.DU
- Previous Close
30.60 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 53.00 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: UP0.DU
View MorePerformance Overview: UP0.DU
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
UP0.DU
20.87%
S&P 500 (^GSPC)
8.60%
1-Year Return
UP0.DU
22.38%
S&P 500 (^GSPC)
6.02%
3-Year Return
UP0.DU
52.41%
S&P 500 (^GSPC)
25.85%
5-Year Return
UP0.DU
49.06%
S&P 500 (^GSPC)
92.15%
Compare To: UP0.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap undefined -
Industry -
Statistics: UP0.DU
View MoreValuation Measures
As of 4/22/2025
Market Cap
2.93B
Enterprise Value
2.43B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.69
Price/Book (mrq)
12.95
Enterprise Value/Revenue
5.00
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--